Your browser doesn't support javascript.
loading
Exploration of clinical preferences in treatment planning of radiotherapy for prostate cancer using Pareto fronts and clinical grading analysis.
Kyroudi, A; Petersson, K; Ozsahin, E; Bourhis, J; Bochud, F; Moeckli, R.
Afiliación
  • Kyroudi A; Institute of Radiation Physics, Lausanne University Hospital, Rue du Grand-Pré 1, CH 1007 Lausanne, Switzerland.
  • Petersson K; Institute of Radiation Physics, Lausanne University Hospital, Rue du Grand-Pré 1, CH 1007 Lausanne, Switzerland.
  • Ozsahin E; Department of Radiation Oncology, Lausanne University Hospital, Rue du Bugnon 46, CH 1011 Lausanne, Switzerland.
  • Bourhis J; Department of Radiation Oncology, Lausanne University Hospital, Rue du Bugnon 46, CH 1011 Lausanne, Switzerland.
  • Bochud F; Institute of Radiation Physics, Lausanne University Hospital, Rue du Grand-Pré 1, CH 1007 Lausanne, Switzerland.
  • Moeckli R; Institute of Radiation Physics, Lausanne University Hospital, Rue du Grand-Pré 1, CH 1007 Lausanne, Switzerland.
Phys Imaging Radiat Oncol ; 14: 82-86, 2020 Apr.
Article en En | MEDLINE | ID: mdl-33458319
INTRODUCTION: Radiotherapy treatment planning is a multi-criteria problem. Any optimization of the process produces a set of mathematically optimal solutions. These optimal plans are considered mathematically equal, but they differ in terms of the trade-offs involved. Since the various objectives are conflicting, the choice of the best plan for treatment is dependent on the preferences of the radiation oncologists or the medical physicists (decision makers).We defined a clinically relevant area on a prostate Pareto front which better represented clinical preferences and determined if there were differences among radiation oncologists and medical physicists. METHODS AND MATERIALS: Pareto fronts of five localized prostate cancer patients were used to analyze and visualize the trade-off between the rectum sparing and the PTV under-dosage. Clinical preferences were evaluated with Clinical Grading Analysis by asking nine radiation oncologists and ten medical physicists to rate pairs of plans presented side by side. A choice of the optimal plan on the Pareto front was made by all decision makers. RESULTS: The plans in the central region of the Pareto front (1-4% PTV under-dosage) received the best evaluations. Radiation oncologists preferred the organ at risk (OAR) sparing region (2.5-4% PTV under-dosage) while medical physicists preferred better PTV coverage (1-2.5% PTV under-dosage). When the Pareto fronts were additionally presented to the decisions makers they systematically chose the plan in the trade-off region (0.5-1% PTV under-dosage). CONCLUSION: We determined a specific region on the Pareto front preferred by the radiation oncologists and medical physicists and found a difference between them.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Phys Imaging Radiat Oncol Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Phys Imaging Radiat Oncol Año: 2020 Tipo del documento: Article